Cannell & Co’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $300K | Sell |
3,805
-335
| -8% | -$23.8K | 0.01% | 233 |
|
|
2023
Q3 | $289K | Sell |
4,140
-550
| -12% | -$39K | 0.01% | 228 |
|
|
2023
Q2 | $324K | Hold |
4,690
| – | – | 0.01% | 223 |
|
|
2023
Q1 | $349K | Hold |
4,690
| – | – | 0.01% | 224 |
|
|
2022
Q4 | $437K | Sell |
4,690
-200
| -4% | -$19.3K | 0.02% | 210 |
|
|
2022
Q3 | $466K | Buy |
4,890
+500
| +11% | +$49.5K | 0.02% | 204 |
|
|
2022
Q2 | $407K | Sell |
4,390
-800
| -15% | -$78.1K | 0.01% | 219 |
|
|
2022
Q1 | $525K | Sell |
5,190
-375
| -7% | -$39.4K | 0.02% | 217 |
|
|
2021
Q4 | $574K | Sell |
5,565
-385
| -6% | -$35.6K | 0.02% | 217 |
|
|
2021
Q3 | $505K | Buy |
5,950
+200
| +3% | +$16.8K | 0.02% | 220 |
|
|
2021
Q2 | $480K | Buy |
5,750
+50
| +0.9% | +$4.09K | 0.01% | 222 |
|
|
2021
Q1 | $429K | Buy |
5,700
+990
| +21% | +$72.1K | 0.01% | 226 |
|
|
2020
Q4 | $322K | Buy |
4,710
+739
| +19% | +$48.1K | 0.01% | 237 |
|
|
2020
Q3 | $232K | Hold |
3,971
| – | – | 0.01% | 228 |
|
|
2020
Q2 | $258K | Sell |
3,971
-300
| -7% | -$18.9K | 0.01% | 219 |
|
|
2020
Q1 | $253K | Sell |
4,271
-1,755
| -29% | -$117K | 0.01% | 206 |
|
|
2019
Q4 | $448K | Buy |
6,026
+255
| +4% | +$17.9K | 0.02% | 197 |
|
|
2019
Q3 | $364K | Sell |
5,771
-879
| -13% | -$52.1K | 0.01% | 204 |
|
|
2019
Q2 | $362K | Sell |
6,650
-225
| -3% | -$12.1K | 0.01% | 200 |
|
|
2019
Q1 | $371K | Buy |
+6,875
| New | +$424K | 0.01% | 203 |
|
|
2018
Q4 | – | Sell |
-3,350
| Closed | -$264K | – | 251 |
|
|
2018
Q3 | $264K | Hold |
3,350
| – | – | 0.01% | 225 |
|
|
2018
Q2 | $216K | Sell |
3,350
-700
| -17% | -$46.1K | 0.01% | 240 |
|
|
2018
Q1 | $252K | Sell |
4,050
-340
| -8% | -$24.4K | 0.01% | 226 |
|
|
2017
Q4 | $318K | Buy |
4,390
+500
| +13% | +$36.4K | 0.01% | 224 |
|
|
2017
Q3 | $316K | Hold |
3,890
| – | – | 0.01% | 215 |
|
|
2017
Q2 | $313K | Buy |
3,890
+215
| +6% | +$17K | 0.01% | 219 |
|
|
2017
Q1 | $288K | Buy |
3,675
+335
| +10% | +$26.7K | 0.01% | 228 |
|
|
2016
Q4 | $264K | Sell |
3,340
-5,670
| -63% | -$459K | 0.01% | 228 |
|
|
2016
Q3 | $802K | Buy |
9,010
+2,690
| +43% | +$254K | 0.03% | 179 |
|
|
2016
Q2 | $605K | Sell |
6,320
-150
| -2% | -$14.9K | 0.02% | 196 |
|
|
2016
Q1 | $671K | Hold |
6,470
| – | – | 0.02% | 191 |
|
|
2015
Q4 | $633K | Sell |
6,470
-1,525
| -19% | -$149K | 0.02% | 197 |
|
|
2015
Q3 | $771K | Buy |
+7,995
| New | +$841K | 0.03% | 191 |
|
Other funds holding CVS
Cannell & Co's CVS Position: Q4 2023 in Review
Cannell & Co reduced its CVS Health (CVS) stake by 8.1% in Q4 2023, selling an estimated $23.8K and leaving 3,805 shares worth $300K. The position accounts for 0.01% of the portfolio, ranked #233.
Cannell & Co first reported a position in CVS in Q3 2015 and has held it in 33 quarters since. The position peaked at $802K in Q3 2016. 2,257 funds tracked by Wall St. Rank hold CVS as of Q4 2023.
- Cannell & Co held 3,805 shares of CVS Health worth $300K as of Q4 2023.
- Cannell & Co sold 335 CVS Health shares in Q4 2023, an estimated $23.8K.
- CVS Health made up 0.01% of Cannell & Co's portfolio in Q4 2023, its #233 holding.
- Cannell & Co first reported a position in CVS Health in Q3 2015 and has held it in 33 quarters since.
- Cannell & Co's CVS Health position peaked at $802K in Q3 2016.
- 2,257 funds tracked by Wall St. Rank held CVS Health as of Q4 2023.
Based on Cannell & Co's 13F filing for Q4 2023, filed 5 Feb 2024.